Research and Publications

One of the areas I am most proud of in our department is our dedication to advancing patient care through research and publication. The fact that our preceptors produce so many posters and publications demonstrates to our residents that it’s possible to successfully balance these activities with their other duties as a pharmacist.

Morgan Jones, PharmD, BCPS, BCCCP, FCCM
Clinical Pharmacy Specialist – Neurocritical Care – Methodist University Hospital


Our department has been incredibly successful in advancing patient care through research and publication. Over the last 5 years, our pharmacists have authored over 200 scholarly works, with 100 involving our pharmacy residents.

Notable Resident Publications

Riha H, Erdman MJ, Vandigo JE, Kimmons LA, Goyal N, Davidson KE, Pandhi A, Jones GM.  “Impact of Moderate Hyperchloremia on Clinical Outcomes in Intracerebral Hemorrhage Patients Treated with Continuous Infusion Hypertonic Saline: A Pilot Study.” Crit Care Med. 2017 May 22. [Epub ahead of print]

Schaapveld-Davis CM, Negrete A, Hudson JQ, Saikumar J, Finch CK, Kocak M, Hu P, Van Berkel MA. Increased Rates of Adverse Glucose Events During Management of Diabetic Ketoacidosis or Hyperosmolar Hyperglycemic State in Patients with End-Stage Renal Disease. Clin Diabetes 2017 May 3; doi:10.2337/cd 16-0060. 

Marler JL, Mohrien KM, Kimmons LA, Vandigo JE, Oliphant C, Bouche A, Jones GM. “Safety of Propofol in Patients with Severe Sepsis or Septic Shock: A Multi-center, Retrospective, Propensity-Matched Cohort Study.”  J Crit Care 2016. [Epub ahead of print].

Courson A, Jones GM, Twilla JD. “Treatment of Hepatic Encephalopathy: Comparing the Effects of Adding Rifaximin to Lactulose.” J Pharm Practice 2016 Jun;29(3):212-7.

Erdman MJ, Doepker BA, Gerlach AT, Phillips G, Elijovich L, Jones GM. Dexmedetomidine versus Propofol for Sedation in the Neurocritical Care Unit: A Comparison of Severe Hemodynamic Disturbances. Crit Care Med. 2014 Jul;42(7):1696-702.

Sakaan SA, Hudson JQ, Oliphant CS, Tolley EA, Cummings C, Alabdan NA, Self TH. Evaluation of Warfarin Dose Requirements in Patients with Chronic Kidney Disease and ESRD. Pharmacotherapy. 2014:34;695-702.

Wallace JL, Reaves AB, Tolley EA, Oliphant CS, Hutchison L, Alabdan NA, Sands CW, Self TH. Comparison of initial warfarin response in obese patients versus non-obese patients. J Thromb Thrombolysis. 2013;36(1):96-101.

Cutshall BT, Duhart BT, Saikumar J, Samarin M, Hutshison L, Hudson JQ. Assessing Guideline-Directed Medication Therapy for Heart Failure In End-Stage Renal Disease. Am J Med Sci 2018 Mar; 355(3):247-251.

Davidson KE, Newell J, Alsherbini K, Krushinski J, Jones GM.  “Safety and Efficiency of Intravenous Push Lacosamide.” Neurocrit Care 2018.  Neurocrit Care 2018 June 11. [Epub ahead of print].

More Information